The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1240
July 31, 2006
View Complete Issue         Table of Contents 2019 
RotaTeq: A New Oral Rotavirus Vaccine
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
RotaTeq: A New Oral Rotavirus Vaccine
July 31, 2006 (Issue: 1240)
The FDA has recently approved RotaTeq (Merck), an oral live, human-bovine reassortant rotavirus vaccine, for use in infants to prevent rotavirus gastroenteritis, a frequent cause of severe diarrhea in infancy.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: RotaTeq: A New Oral Rotavirus Vaccine
Article code: 1240b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.